SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-20-134283
Filing Date
2020-12-10
Accepted
2020-12-10 17:19:43
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2038201-2_424b5.htm 424B5 773274
2 GRAPHIC lg_nabriva-4c.jpg GRAPHIC 523958
  Complete submission text file 0001104659-20-134283.txt   1459657
Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-248530 | Film No.: 201381480
SIC: 2834 Pharmaceutical Preparations